Cited by 2,206Hippo pathway signaling and YAP/TAZMicrotubule and mitosis dynamicsPI3K/AKT/mTOR signaling in cancer

Hippo pathway in organ size control, tissue homeostasis, and cancer

Open access
Yu, Fa-Xing, Zhao, Bin, Guan, Kun-Liang·2015·Cell

Abstract

Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2015.10.044

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Single molecule FISH measurements for Amotl2 demonstrated increased expression of this transcript in Hbo1-depleted hepatocytes.

    “Notably, single molecule FISH measurements for Amotl231, a well-known YAP target, demonstrated the increased expression of this transcript in Hbo1-depleted hepatocytes (Figure 4C).”

    From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [31]

    The cited review does not report single-molecule FISH measurements or increased Amotl2 expression in Hbo1-depleted hepatocytes; the citing sentence points to its own Figure 4C for that result. The review’s “Hippo Pathway in Early Embryonic Development” section mentions AMOT/AMOTL2 depletion in embryos, but does not address this measurement. Searches for Amotl2 and Hbo1-depleted hepatocytes found no supporting passage. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Single cell molecule FISH of YAP target genes Cyr61 and Amotl2 validated their dramatically higher expression in vivo in the absence of HBO1 and their attenuation following HBO1 overexpression.

    “Single cell molecule FISH of YAP target genes, Cyr61 and Amotl231, validated their dramatically higher expression in vivo in the absence of HBO1 (Figure 5F, 5G and S5G, and their attenuation following HBO1 overexpression (Figure S5H).”

    From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [31]

    The citation is attached to the identification of Cyr61 and Amotl2 as YAP target genes, not to the citing authors’ FISH results. The review’s ‘YAP/TAZ and Yki as Major Effectors of Hippo Signaling’ section discusses YAP target genes generally but does not identify Cyr61 or Amotl2 as targets. Searches for those genes and HBO1 found no passage supporting the specific claim; the review mentions AMOTL2 in a different context, as a Hippo-pathway component. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Some hits from earlier CRISPR screens overlap with shared dependencies found in this study, including ELP3, ELP4, PKN2 and RPN1 in H358, EXT1, WWTR1 and SHOC2 in MIAPaCa-2, and PGM3 in the 2D component of the 2D versus 3D screen.

    “The “hits” in the earlier papers reveal some shared dependencies with our study (e.g., ELP3, ELP4, PKN2, RPN1 in the H358 screen; EXT1, WWTR1, SHOC2 in MIAPaCa-2 cells, PGM3 in the 2D component of the 2D vs 3D screen; compare with Fig. 1D with References 43,44).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yu, F.-X., Zhao, B., & Guan, K.-L.
Affiliations
  • Fudan University (CN)
  • Zhejiang University (CN)
  • University of California San Diego (US)
Corresponding author
  • Yu, Fa-Xing
  • Guan, Kun-Liang
Venue
Cell
Publisher
Elsevier BV
Published
2015-11
Volume
163
Issue
4
Pages
811-828
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2148056172
Cited by
2,206
References
217
Citations by year
2026: 132 · 2025: 165 · 2024: 214 · 2023: 222 · 2022: 251 · 2021: 260 · 2020: 270 · 2019: 212 · 2018: 222 · 2017: 159 · 2016: 93 · 2015: 1 · 2014: 1
FWCI
15.84
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (5p50dk039255-20)
  • National Eye Institute (R01EY022611, EY022611)
  • National Cancer Institute (R35CA196878, CA132809, R01CA108941, R01CA132809, CA196878)
  • National Institute of General Medical Sciences (GM-51586, R01GM051586)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P50-DK039255)
  • National Institute of Dental and Craniofacial Research (DE015964, R01DE015964)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
Hippo signaling pathway, organ size control, tissue homeostasis, YAP, TAZ, transcriptional coactivator, cell proliferation, apoptosis, stemness, cell-cell contact, cell polarity, mechanical cues, G protein-coupled receptors, cellular energy status, carcinogenesis, cancer therapy targets
MeSH terms
Animals, Cell Physiological Phenomena, Homeostasis, Humans, Neoplasms, Organ Size, Signal Transduction, Protein Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review